Cost-Effective Molecular Diagnostic Identifies Clostridium difficile

The test for Clostridium difficile uses an integrated disposable cartridge containing all necessary reagents and an inexpensive bench-top analyzer that executes the assay, interprets the results, and provides electronic output to the clinician.

The sensitive, easy-to-use, integrated cartridge system allows for more accurate and information-rich detection of infectious diseases, allowing providers to diagnose and define a clear treatment path sooner for improved patient outcomes, shorter hospital stays, and significant cost savings.

Great Basin Corporation (Salt lake City, Utah, USA) a privately held life sciences company developing sample-to-result molecular diagnostic solutions, has submitted a 510(k) application to the US Food and Drug Administration (FDA) for its first molecular diagnostic test for C. More...